Can remote learning help with cancer research training and education?
Darcie Green, Shaji K. Kumar, Donna Black, and the NCCN COVID-19 Vaccination Advisory Committee received of the 2024 National Comprehensive Cancer Network awards.
Lessons in remote learning from NASDC—an educational program forced online by COVID-19
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Administrative director, Cancer Research Training & Education Coordination (CRTEC), Abramson Cancer Center, University of Pennsylvania
Assistant professor, psychiatry, Harvard Medical School; Psychologist, Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute
Vice president, scientific education & training, Memorial Sloan Kettering Cancer Center
Table of Contents
YOU MAY BE INTERESTED IN
The COVID-19 pandemic was associated with significant changes in diagnoses of all cancer types in 2020, with a 14.4% overall decline in the number of reported cancer cases in cancer centers accredited by the Commission on Cancer (CoC) compared with the prior year.
A study demonstrated that viral immune evasion enabled breakthrough infections of COVID-19 in patients with lung cancer, highlighting the importance of effective monitoring mechanisms, such as anti-N serology, to track infection rates in specific vulnerable populations.
Katalin Karikó (left) and Drew Weissman (right)Photo credit: Niklas Elmehed © Nobel Prize OutreachKatalin Karikó and Drew Weissman were jointly awarded the 2023 Nobel Prize in Physiology or Medicine “for their discoveries concerning base modifications that enabled the development of effective mRNA vaccines against COVID-19.”
A “weighted” lottery program designed to ensure that people living in the most disadvantaged U.S. neighborhoods would be offered a scarce, potentially life-saving medication proved feasible in a large health system. The approach can improve equity in receipt of the drug by people disproportionately affected by disease, according to an analysis published today in JAMA Health Forum by University of Pittsburgh and UPMC scientist-clinicians.
Delays in cancer screening during the COVID-19 pandemic will likely cause a significant increase in cancer cases that could have been caught earlier with screening, and may now be diagnosed at later stages, placing an increased burden on an already strained healthcare system, according to a new research article published in the Journal of the American College of Surgeons.
